Ardigen
Krakow, PL · Founded 2015 · 136 employees on LinkedIn · 1 known investors
Find your way into Ardigen
Sign up to see every warm intro you have to Ardigen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ardigen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.
Founders & leadership
Board
P
PrzewiezlikowskiFounder, CEO (of Ryvu Therapeutics), President of Supervisory Board
Investors · 1
Funding
SEC filings, press & company announcements$5.4M disclosed across 1 round · 2020
- $5.4MraisedSep 2020 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Ardigen do?
- Ardigen is an AI-driven Contract Research Organization providing bioinformatics and machine learning solutions to accelerate drug discovery for biotech and pharmaceutical companies. The company leverages artificial intelligence, computational biology, and software engineering to help clients identify drug candidates and increase the probability of clinical success.
- Who are Ardigen's investors?
- Ardigen's investors include Pointer.Capital.
- How much funding has Ardigen raised?
- Ardigen has disclosed $5.4M raised across 1 round.
- Where is Ardigen headquartered?
- Ardigen is headquartered in Krakow, PL.


